Microbot Medical Inc.

NasdaqCM MBOT

Microbot Medical Inc. Price to Earnings Ratio (P/E) on February 06, 2025

Microbot Medical Inc. Price to Earnings Ratio (P/E) is NA on February 06, 2025, a NA change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Microbot Medical Inc. 52-week high Price to Earnings Ratio (P/E) is -1.84 on April 25, 2024, which is NA below the current Price to Earnings Ratio (P/E).
Microbot Medical Inc. 52-week low Price to Earnings Ratio (P/E) is -6.14 on January 06, 2025, which is NA below the current Price to Earnings Ratio (P/E).
Microbot Medical Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is -2.32.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NasdaqCM: MBOT

Microbot Medical Inc.

CEO	Mr. Harel Gadot
IPO Date	March 25, 1992
Location	United States
Headquarters	25 Recreation Park Drive
Employees	21
Sector	Technology
Industries Robotics 3D Printing Medical Instruments

Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Key trends

Past 5 years